CVS Health, the United States’s second-largest pharmacy chain, recently announced that it will be pulling decongestants containing phenylephrine off the shelves of its stores across the nation. This decision is part of the company’s aim to reduce the prevalence of medication errors and ensure customer safety. Phenylephrine, a common ingredient found in decongestants and nasal sprays, has become increasingly controversial in recent years due to its numerous side effects. These effects include dizziness, nausea, headache, vomiting, difficulty breathing, increased blood pressure, and even heart palpitations. Some studies have also linked its use to the development of high blood pressure and other cardiovascular issues. CVS Health was praised for its decision to remove decongestants with phenylephrine due to its potential dangers. William O’Donohue, a professor of psychology at the University of Nevada Reno, stated that the move “could save thousands of lives since the risks of phenylephrine far exceed any benefits.” He went on to say that “it’s up to pharmacists and others in the medical profession to act responsibly and keep their patients safe.” The company also noted that they will continue to work with regulators and manufacturers to minimize the presence of these products in the United States. In an effort to reduce medication errors, CVS Health has stated that it will continue to review the ingredients found in over-the-counter medications and provide additional resources for customers. For example, they have launched an educational campaign to ensure that patients understand the risks associated with taking medications containing phenylephrine and other active ingredients. The decision by CVS Health to remove decongestants with phenylephrine from its shelves is a step in the right direction for reducing the prevalence of medication errors. Not only will patients benefit from this move, but it will also help support the health of our nation as a whole.